Angiotensin II-dependent superoxide: Effects on hypertension and vascular dysfunction

Hypertension

Volumn 52, Issue 1, 2008, Pages 51-56

  Welch, William J ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIN; HYDROGEN PEROXIDE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; NEBIVOLOL; PROSTAGLANDIN SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TEMPOL; VALSARTAN;

ANEURYSM; AORTA DISSECTION; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD VESSEL INJURY; ENDOTHELIAL DYSFUNCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FUNCTION; NONHUMAN; OXIDATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASOCONSTRICTION; ANIMAL; BLOOD VESSEL; BRAIN; GENETICS; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT;

ANGIOTENSIN II; ANIMALS; BLOOD VESSELS; BRAIN; HUMANS; HYPERTENSION; KIDNEY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; SUPEROXIDES;

EID: 46449086217     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.090472     Document Type: Review

References (49)

1. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:C82-C97.
2. Choi H, Leto TL, Hunvady L, Catt KJ, Bae YS, Rhee SG. Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase. J Biol Chem. 2008;28:255-267.
3. Lassègue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88: 888-894.
4. Ding L, Chapman A, Boyd R, Wang HD. ERK activation contributes to regulation of spontaneous contractile tone via superoxide anion in isolated rat aorta of angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol. 2007;292:H2997-H3005.
5. Ni W, Zhan Y, He H, Maynard E, Balschi JA, Oettgen P. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47phox gene expression in response to angiotensin II. Circ Res. 2007;101: 962-964.
6. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HHHW, Busse R, Schroder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidase but an antioxidant. Hypertension. 2008;51:211-217.
7. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation. 2005;25:112:2677-2685.
8. Yogi A, Mercure C, Touyz J, Callera GE, Montezano AC, Aranha AB, Tostes RC, Reudelhuber T, Touyz RM. Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension. 2008;51:500-506.
9. Bendall JK, Rinze R, Adlam D, Tatham AL, de Bono J, Channon KM. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ Res. 2007;13:100:1016-1025.
10. Dikalova A, Clempus R, Lassègue B, Cheng G, McCoy J, Dikalova S, San Martin A, Lyle A, Weber DS, Weiss D, Taylor WR, Schmidt HH, Owens GK, Lambeth JD, Griendling KK. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation. 2005;112:2668-2676.
11. Modlinger P, Chabrashvili T, Gill PS, Mendonca M, Harrison DG, Griendling KK, Li M, Raggio J, Wellstein A, Chen Y, Welch WJ, Wilcox CS. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension. 2006;47:238-244.
12. Tian N, Moore RS, Braddy S, Rose RA, Gu JW, Hughson MD, Manning RD Jr. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol. 2007;293: H3388-H3395.
13. Fujii A, Nakano D, Katsuragi M, Ohkita M, Takaoka M, Ohno Y, Matsumura Y. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension. Eur J Pharmacol. 2006;552:131-134.
14. Jalil JE, Perez A, Ocaranza MP, Bargetto J, Galaz A, Lavandero S. Increased aortic NAPDH oxidase activity in rats with genetically high angiotensin-converting enzyme levels. Hypertension. 2005;46: 1362-1367.
15. Kobayashi A, Ishikawa K, Matsumato H, Kimura S, Kamiyama Y, Maruyama Y. Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II-mediated cardiac hypertrophy. Hypertension. 2007;50:1040-1048.
16. Hingtgen SD, Tian X, Yang J, Dunlay SM, Peek AS, Wu Y, Sharma RV, Engelhardt JF, Davisson RL. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics. 2006;26:180-191.
17. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Abe Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension. 2005;45:438-444.
18. Touyz RM, Mercure C, Ying H, Javeshghani D, Yao G, Callera GE, Yogi A, Loachard N, Reudelhuber TL. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension. 2005;45:530-537.
19. Zhou MS, Hernandez SI, Pagano PJ, Jaimes EA, Raij L. Reduced NADPH oxidase in low renin hypertension: link among angiotensin II, atherogenesis and blood pressure. Hypertension. 2006;47:81-86.
20. Wei Y, Whaley-Connell AT, Chen K, Habibi J, Uptegrove GM-E, Clark SE, Stump CS, Ferrario CM, Sowers JR. NADPH oxidase contributes to vascular inflammation, insulin resistance and remodeling in the transgenic (mRen2) rat. Hypertension. 2007;50:384-391.
21. Gavassi G, Deffert C, Trocme C, Schappi M, Herrmann FR, Krause KH. NOX1 deficiency protects form aortic dissections in response to angiotensin II. Hypertension. 2007;50:189-196.
22. Thomas M, Gavrila D, McCormick ML, Miller FJ Jr, Daugherty A, Cassis LA, Dellsperger KC, Weintraub NL. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation. 2006;114:404-413.
23. Kimura S, Zhang G-X, Nishiyama A, Shokoji T, Yao L, Fan Y-Y, Rahman M, Suzuki T, Maeta H, Abe Y. Role of NADPH oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension. 2005;45: 860-866.
24. Akishita M, Nagai K, Xi H, Yu W, Sudoh N, Watanabe T, Ohara-Imaizumi M, Nagamatsu S, Kozaki K, Horiuchi M, Toba K. Renin-angiotensin system modulates oxidative stress-induced endothelial cell apo-ptosis in rats. Hypertension. 2005;45:1188-1193.
25. Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H, Horiuchi M. Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress. Hypertension. 2005;45:545-551.
26. 2. Hypertension. 2005;46: 732-737.
27. Chrissobolis S, Didion SP, Kinzenbaw DA, Schrader LI, Dayal S, Lentz SR, Faraci FM. Glutathione perioxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension. 2008; 51:872-877.
28. Schrader LI, Kinzenbaw DA, Johnson AW, Faraci FM, Didion SP. IL-deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arteriocler Thromb Vasc Biol. 2007;27: 2576-2581.
29. Luther JM, Gainer JV, Murphey LJ, Yu C, Vaughan DE, Morrow JD, Brown NJ. Angiotensin II induces IL-6 in humans through a mineralo-corticoid receptor-dependent mechanism. Hypertension. 2006;48: 1050-1057.
30. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced efflux of extracellular calcium in neural cells. Hypertension. 2006;45:717-723.
31. Nozoe M, Hirooka Y, Koga Y, Sagara Y, Kishi T, Engelhardt JF, Sunagawa K. Inhibition o f Rac-1 derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats. Hypertension. 2007;50: 62-68.
32. Mollnau H, Wendt M, Szöcs K, Lassègue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Förstermann U, Meinertz T, Griendling K, Münzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 2002;90: E58-E65.
33. Wang G, Anrather J, Glass MJ, Tarsitano MJ, Zhou P, Frys KA, Pickel VM, Iadecola C. Nox2, Ca2+ and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension. 2007;48:482-489.
34. Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, Mulsch A, Li H, Forstermann U, Munzel T. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension. 2006;48:677-684.
35. Zhao W, Swanson SA, Ye J, Li X, Shelton JM, Zhang W, Thomas GD. Reactive oxygen species impair sympathetic vasoregulation in skeletal muscle in angiotensin II-dependent hypertension. Hypertension. 2006;48: 637-643.
36. Schupp N, Schmid U, Rutkowski P, Lakner U, Kanase N, Heidland A, Stopper H. Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. Am J Physiol Renal Physiol. 2007;292:F1427-F1434.
37. Whaley-Connell AT, Habibi J, Nistala R, Cooper SA, Karuparthi PR, Hayden MR, Rehmer N, DeMarco VG, Andresen BT, Wei Y, Ferrario C, Sowers JB. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Hypertension. 2008; 51:474-480.
38. Welch WJ, Chabrashvili T, Solis G, Chen Y, Gill PS, Wang X, Ji H, Sandberg K, Jose P, Wilcox CS. Role of extracellular superoxide dis-mutase in the mouse angiotensin slow pressor response. Hypertension. 2006;48:934-941.
39. Gongora MC, Qin Z, Laude K, Kim HW, McCann L, Folz JR, Dikalov S, Fukai T, Harrison DG. Role of extracelllular superoxide dismutase in hypertension. Hypertension. 2006;48:473-481.
40. Kopkan L, Castillo A, Navar LG, Majid DS. Enhanced superoxide generation modulates renal function in Ang II-induced hypertensive rats. Am J Physiol Renal Physiol. 2006;290:F80-F86.
41. Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS. Angiotensin-induced defects in renal oxygenation: Role of oxidative stress. Am J Physiol Heart Circulation. 2005;288:H22-H28.
42. McBride MW, Brosnan MJ, Mathers J, McLellan LI, Miller WH, Graham D, Hanlon N, Hamilton CA, Polke JM, Lee WK, Dominiczak AF. Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension. 2005; 45:786-792.
43. Wu R, Laplante M-A, de Champlain J. Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension and cardiac hypertrophy in rats. Hypertension. 2005;45:1139-1144.
44. Jaimes EA, Zhou MS, Pearse DD, Puzis L, Raij L. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. Am J Physiol Renal Physiol. 2008;294: F385-F392.
45. Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, Segnani C, Ippolito C, Antonioli L, Blandizzi C, Taddei S, Salvetti A, Del Tacca M. Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension. 2007;49:679-686.
46. Ceravolo GS, Fernandes L, Munhoz CD, Fernandes DC, Tostes RC, Laurindo FR, Scovone C, Fortes ZB, Carvalho MH. Angiotensin II chronic infusion induces B1 receptor expression in aorta of rats. Hypertension. 2007;50:756-761.
47. Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension. 2005;46: 943-947.
48. Cingolani HE, Villa-Abrille MC, Cornelli M, Nolly A, Ennis IL, Gar-ciarena C, Suburo AM, Torbidoni V, Correa MV, Camiliónde Hurtado MC, Aiello EA. The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species. Hypertension. 2006;47: 727-734.
49. An SJ, Boyd R, Zhu M, Chapman A, Pimentel DR, Wang HD. NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts. Cardiovasc Res. 2007;75:702-709.